Protagonist Therapeutics
Protagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities (NCEs) that can potentially transform existing treatment paradigms in disease areas with significant unmet medical needs.
Basic Information
- Category: Autoimmune
- Founded: 2006
- Headquarters: Newark, CA
- Website: protagonist-inc.com
Documented Facts
- Phone: (510) 474-0170 (No linked source recorded for this statement.)
- Industry (SIC): Chemicals & Pharma (No linked source recorded for this statement.)
- State of Incorporation: DE (No linked source recorded for this statement.)
- Stock ticker: PTGX (Nasdaq) (No linked source recorded for this statement.)
Evidence and Sources
- Protagonist Therapeutics — Official Site (official)
- Protagonist Therapeutics on linkedin (social)
- Protagonist Therapeutics, Inc — SEC EDGAR (reference)
Citation Guidance
Explore Autoimmune profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Protagonist Therapeutics.
- Canonical profile: https://brandsource.ai/brands/protagonist-therapeutics
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/protagonist-therapeutics/json-ld
- Citation profile API: https://brandsource.ai/api/brands/protagonist-therapeutics/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (94/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2025-10-28T04:26:08.933Z
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Protagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities (NCEs) that can potentially transform existing treatment paradigms in disease areas with significant unmet medical needs.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 2 supporting sources linked.
- 4 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.